Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05534607 · ClinicalTrials.gov registry record · NA

Natives Engaged in Alzheimers Research - 'Ike Kupuna

A NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment, sponsored by University of Hawaii.

Recruiting
Registry status
NA
Development phase
192
Enrollment target
3
Study locations

NCT05534607: Recruiting NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment, sponsored by University of Hawaii.

NCT05534607 is a NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment that is actively recruiting participants, run by University of Hawaii. The registered enrollment target is 192 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05534607, a NA study of Mild Cognitive Impairment and Subjective Cognitive Impairment, is actively recruiting participants, sponsored by University of Hawaii.

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
3
Study locations

Study Summary

This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

Primary Outcome

Vascular risk factor assessed using Omron©HEM-907XL

Interventions

  • BEHAVIORAL Ola Mau i ka Hula

Study Locations (3)

Hawaii

  • Kula No Na Po'e - Honolulu
  • Kokua Kalihi Valley - Honolulu
  • Hui No Ke Ola Pono - Wailuku

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2022-09-15
Est. Completion 2027-04-30
Phase NA
University of Hawaii

77 total trials

What NCT05534607 shows while recruiting

NCT05534607 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Ola Mau i ka Hula is the first listed.

NCT05534607 reports a single indexed study location in Hawaii.

Frequently Asked Questions

What is clinical trial NCT05534607 about?

NCT05534607 is a clinical study titled "Natives Engaged in Alzheimers Research - 'Ike Kupuna". This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

What is the current status of trial NCT05534607?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2022-09-15. Estimated completion is 2027-04-30.

What conditions does trial NCT05534607 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Subjective Cognitive Impairment.

What interventions are being tested in trial NCT05534607?

The interventions under investigation include: Ola Mau i ka Hula (BEHAVIORAL).

Who is sponsoring clinical trial NCT05534607?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05534607 being conducted?

This trial has 3 study locations across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05534607's enrollment target sits among peer trials

192 53rd of 205 higher than 153 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05534607, the US trial registry maintained by the National Library of Medicine. NCT05534607 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.